Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
04/01/2010 | US20100081810 C-Pyrazole A2A Receptor Agonists |
04/01/2010 | US20100081697 Crystalline freebase of 4'-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]imidazol-1-ylmethyl}-3'-fluorobiphenyl-2-carboxylic acid; stability; high melting point; nondeliquescent; hypotensive agents; heart failure; angiotensin II type 1 receptor antagonist; enkephalinase inhibitor |
04/01/2010 | US20100081671 Cycloalkylamine substituted isoquinoline derivatives |
04/01/2010 | US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
04/01/2010 | US20100081652 Cinnamoyl Compound and Use Thereof |
04/01/2010 | US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
04/01/2010 | US20100081643 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
04/01/2010 | US20100081639 Pharmaceutical composition comprising fermented ginseng |
04/01/2010 | US20100080846 Dipyridamole and acetylsalicylic acid formulations and process for preparing same |
04/01/2010 | US20100080810 Methods of treating diseases with anti-vegf antibodies |
04/01/2010 | CA2738285A1 Method for producing lipids |
04/01/2010 | CA2738282A1 Method for concentrating lipids |
04/01/2010 | CA2738147A1 Solid pharmaceutical composition |
04/01/2010 | CA2737739A1 Heteroaryl antagonists of prostaglandin d2 receptors |
03/31/2010 | EP2169059A1 Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis |
03/31/2010 | EP2169038A1 A process for decreasing environmental pollutants in an oil or a fat, and a fish feed product |
03/31/2010 | EP2168984A1 Human antibodies that bind human IL-12 and methods for producing |
03/31/2010 | EP2168969A2 Racemization and Enantiomer Separation of Clopidogrel |
03/31/2010 | EP2168960A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
03/31/2010 | EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
03/31/2010 | EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof |
03/31/2010 | EP2168952A1 Morpholine derivative |
03/31/2010 | EP2168600A1 Therapeutic or prophylactic agent for cerebral aneurysm |
03/31/2010 | EP2168581A2 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
03/31/2010 | EP2168576A2 New utilities of tricyclic compounds |
03/31/2010 | EP2167482A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases |
03/31/2010 | EP2167472A2 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
03/31/2010 | EP2167113A2 Neuroplastin derived peptides |
03/31/2010 | EP2167109A2 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue |
03/31/2010 | EP2167099A2 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine |
03/31/2010 | EP2167092A2 Quinazoline derivatives as pi3 kinase inhibitors |
03/31/2010 | EP2167070A1 Use of nitric oxide releasing compounds in the treatment of chronic pain |
03/31/2010 | EP2166847A1 Cetp inhibitors derived from benzoxazole arylamides |
03/31/2010 | EP1786814B1 Bicyclononene derivatives as renin inhibitors |
03/31/2010 | EP1758596B1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
03/31/2010 | EP1244460B1 Use of dipyridinium compounds for treating a disease characterized by proliferating cells containing nitric oxide synthase |
03/31/2010 | CN101688178A Stem cell-derived retinal pigment epithelial cells |
03/31/2010 | CN101687916A Inflammation treatment, detection and monitoring via trem-1 |
03/31/2010 | CN101687875A Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals |
03/31/2010 | CN101687873A Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors |
03/31/2010 | CN101687869A Heterocyclic compounds useful as MK2 inhibitors |
03/31/2010 | CN101687855A Phthalazinone derivatives and their use as medicament to treat cancer |
03/31/2010 | CN101687850A Substituted pyrimidines as adenosine receptor antagonists |
03/31/2010 | CN101687847A N5-(2-ethoxyethyl)-N3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
03/31/2010 | CN101687844A Imidazole derivatives as CCR2 receptor antagonists |
03/31/2010 | CN101687807A 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
03/31/2010 | CN101687805A Benzazepine derivatives useful as vasopressin antagonists |
03/31/2010 | CN101687047A Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
03/31/2010 | CN101687032A Antagonist antibodies against ephb3 |
03/31/2010 | CN101687014A compositions and methods for treating pathologic angiogenesis and vascular permeability |
03/31/2010 | CN101687008A Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin |
03/31/2010 | CN101686970A Synergistic combination of anthranilamide pyridinureas and benzamide derivatives |
03/31/2010 | CN101686959A Combination therapy with a compound acting as a platelet ADP receptor inhibitor |
03/31/2010 | CN101686953A Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation |
03/31/2010 | CN101686919A Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation |
03/31/2010 | CN101686724A Kit of nutritional compositions for infants with fat and carbohydrate content adapted to the particular stage of development |
03/31/2010 | CN101684099A Propionic acid derivative of substituted aromatic ring and aromatic heterocycle and preparation method and application thereof |
03/31/2010 | CN101684098A 5-lipoxygenase inhibitor and preparation method, medical composite and application thereof |
03/31/2010 | CN101684091A cannabinoid receptor ligands |
03/31/2010 | CN101683533A Gene transfer-mediated angiogenesis therapy |
03/31/2010 | CN101683531A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
03/31/2010 | CN101683530A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
03/31/2010 | CN101683529A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
03/31/2010 | CN101683526A Pharmaceutical composition containing angiotensin II receptor antagonist, B vitamins and gingo biloba extract |
03/31/2010 | CN101683508A Capsule for strengthening heart and boosting pressure |
03/31/2010 | CN101683507A Traditional Chinese medicine composition for supplementing qi and invigorating blood circulation |
03/31/2010 | CN101683506A Traditional Chinese medicine composition for treating hemorrhoids |
03/31/2010 | CN101683504A Preparation method of relieved pill for activating blood circulation to dissipate blood stasis |
03/31/2010 | CN101683503A Traditional Chinese medicine composition for nourishing heart and strengthening heart |
03/31/2010 | CN101683502A Chinese medicinal composition for promoting blood circulation, benefiting qi and strengthening brain |
03/31/2010 | CN101683493A Traditional Chinese medicine composition for cerebral hemorrhage |
03/31/2010 | CN101683491A Traditional Chinese medicine composition with function of promoting lactation and removing collaterals |
03/31/2010 | CN101683478A Traditional Chinese medicine composition for thrombolysis |
03/31/2010 | CN101683475A Prescription capable of comprehensively repairing cardio-cerebrovascular cycle system and preparation method |
03/31/2010 | CN101683471A Traditional Chinese medicine composition with function of brain tonic and vein relaxing |
03/31/2010 | CN101683465A Preparation method of flavored pill for tranquilizing mind and calming heart |
03/31/2010 | CN101683463A Traditional Chinese medicine composition for nourishing yin and recovering vein |
03/31/2010 | CN101683458A Application of a traditional Chinese medicine composition in preparation of medicament for treating vertigo |
03/31/2010 | CN101683456A Traditional Chinese medicine composition for suppressing hyperactive liver, tranquilizing endogenous wind, eliminating phlegm and removing blood stasis |
03/31/2010 | CN101683455A Traditional Chinese medicine composition for bowel lavage |
03/31/2010 | CN101683449A Preparation method of ointment containing lotus and mulberry |
03/31/2010 | CN101683443A Chinese medicinal composition for resolving stasis and strengthening heart |
03/31/2010 | CN101683441A Traditional Chinese medicine composition for invigorating blood circulation and dissolving stasis |
03/31/2010 | CN101683430A Traditional Chinese medicine composition for treating lacunar infarction |
03/31/2010 | CN101683428A Traditional Chinese medicine composition with function of gore removing and vein relaxing |
03/31/2010 | CN101683419A Traditional Chinese medicine composition for cooling the blood and stopping the blood |
03/31/2010 | CN101683418A Preparation method of navel applying ointment for reducing blood pressure |
03/31/2010 | CN101683417A Traditional Chinese medicine composition with function of warming yang and gore removing |
03/31/2010 | CN101683416A Natural composition for prevention and control of cardiovascular and cerebrovascular diseases, preparation method and uses thereof |
03/31/2010 | CN101683406A Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing hypertension |
03/31/2010 | CN101683405A Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing brain stroke |
03/31/2010 | CN101683394A Externally applied patch for treating phlebitis and method for producing the same |
03/31/2010 | CN101683387A Medication and preparation method and application thereof |
03/31/2010 | CN101683386A Formula of Chinese medicinal liquor having function of reducing blood pressure and preparation method thereof |
03/31/2010 | CN101683368A medicinal composition for anti-stroke and anti-sequelae thereof, improving heart cerebral ischemia, preparation process and preparation thereof |
03/31/2010 | CN101683363A Composition preparation of ginkgo biloba extract and dipyridamole and preparation method thereof |
03/31/2010 | CN101683360A Extraction and purifying technology of propolis flavones and anticancer mechanism thereof |
03/31/2010 | CN101683348A Application of cholestane-3 beta, 5 alpha, 6 beta-triol in preparation of neuronal protection medicine |
03/31/2010 | CN101683343A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury |
03/31/2010 | CN101683338A Application of hirsutine in preparing medicament for treating myocardial damage |